JBM
2161.HKJBM (Healthcare) Limited Price (2161.HK)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
883,696,000
(0.8597)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
JBM (Healthcare) LimitedCurrency: HKD
| YEAR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
264,332,000.00
+0% |
307,515,000.00
+16% |
381,542,000.00
+24% |
397,158,000.00
+4% |
406,139,000.00
+2% |
520,323,000.00
+28% |
648,415,000.00
+25% |
||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 118,143,000.00 | 137,830,000.00 | 191,363,000.00 | 216,218,000.00 | 263,838,000.00 | 332,403,000.00 | 310,334,000.00 | ||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
146,189,000.00
+0% |
169,685,000.00
+16% |
190,179,000.00
+12% |
180,940,000.00
-5% |
142,301,000.00
-21% |
187,920,000.00
+32% |
338,081,000.00
+80% |
||||||||||||
| Gross Profit Ratio | (0.55%) | (0.55%) | (0.50%) | (0.46%) | (0.35%) | (0.36%) | (0.52%) | ||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 9,000.00 | 235,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
| General and Administrative | 26,684,000.00 | 32,197,000.00 | 40,362,000.00 | 41,816,000.00 | 41,424,000.00 | 53,777,000.00 | 41,685,000.00 | ||||||||||||
| Selling, General & Admin... | 83,868,000.00 | 94,514,000.00 | 129,362,000.00 | 110,028,000.00 | 105,940,000.00 | 120,149,000.00 | 180,212,000.00 | ||||||||||||
| Selling & Marketing Exp... | 57,184,000.00 | 62,317,000.00 | 89,000,000.00 | 85,705,000.00 | 81,225,000.00 | 83,961,000.00 | 138,527,000.00 | ||||||||||||
| Depreciation and Amortiz... | 29,820,000.00 | 29,680,000.00 | 35,862,000.00 | 43,602,000.00 | 47,783,000.00 | 43,632,000.00 | 46,521,000.00 | ||||||||||||
| Other Expenses | 1,235,000.00 | 2,025,000.00 | 2,291,000.00 | 2,458,000.00 | 2,444,000.00 | 2,706,000.00 | -16,336,000.00 | ||||||||||||
| Total Operating Expenses | 95,037,000.00 | 104,805,000.00 | 146,418,000.00 | 110,028,000.00 | 105,940,000.00 | 120,149,000.00 | 163,876,000.00 | ||||||||||||
| Cost and Exponses | 213,180,000.00 | 242,635,000.00 | 337,781,000.00 | 326,246,000.00 | 369,778,000.00 | 452,552,000.00 | 474,210,000.00 | ||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
53,554,000.00
+0% |
66,520,000.00
+24% |
51,848,000.00
-22% |
70,912,000.00
+37% |
36,361,000.00
-49% |
67,771,000.00
+86% |
174,205,000.00
+157% |
||||||||||||
| Operating Income Ratio | (0.20%) | (0.22%) | (0.14%) | (0.18%) | (0.09%) | (0.13%) | (0.27%) | ||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 1,148,000.00 | 2,292,000.00 | 5,892,000.00 | 175,000.00 | 18,000.00 | 272,000.00 | 762,000.00 | ||||||||||||
| Interest Expenses | 1,733,000.00 | 1,390,000.00 | 845,000.00 | 7,409,000.00 | 6,407,000.00 | 8,209,000.00 | 8,498,000.00 | ||||||||||||
| Total Other Income/Exp... | -1,733,000.00 | 3,329,000.00 | 2,118,000.00 | -8,595,000.00 | -8,198,000.00 | -10,142,000.00 | -9,315,000.00 | ||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 83,374,000.00 | 96,200,000.00 | 87,710,000.00 | 114,514,000.00 | 84,144,000.00 | 111,403,000.00 | 220,726,000.00 | ||||||||||||
| EBITDA ratio | (0.32%) | (0.34%) | (0.24%) | (0.29%) | (0.21%) | (0.21%) | (0.34%) | ||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 51,821,000.00 | 69,849,000.00 | 53,966,000.00 | 42,867,000.00 | 32,536,000.00 | 78,831,000.00 | 164,890,000.00 | ||||||||||||
| Income Before Tax Ratio | (0.20%) | (0.23%) | (0.14%) | (0.11%) | (0.08%) | (0.15%) | (0.25%) | ||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 7,975,000.00 | 10,581,000.00 | 9,669,000.00 | 11,062,000.00 | 7,417,000.00 | 13,570,000.00 | 27,680,000.00 | ||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | 42,379,000.00
+0% |
52,459,000.00
+24% |
41,022,000.00
-22% |
22,600,000.00
-45% |
24,620,000.00
+9% |
57,093,000.00
+132% |
130,463,000.00
+129% |
||||||||||||
| Net Income Ratio | (0.16%) | (0.17%) | (0.11%) | (0.06%) | (0.06%) | (0.11%) | (0.20%) | ||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.05 | 0.06 | 0.05 | 0.03 | 0.03 | 0.06 | 0.15 | ||||||||||||
| Diluted EPS | 0.05 | 0.06 | 0.05 | 0.03 | 0.03 | 0.06 | 0.15 | ||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 893,686,000.00 | 893,686,000.00 | 893,686,000.00 | 893,686,000.00 | 893,686,000.00 | 891,326,000.00 | 883,895,663.00 | ||||||||||||
| Diluted Share Outstanding | 893,686,000.00 | 893,686,000.00 | 893,686,000.00 | 893,686,000.00 | 893,686,000.00 | 891,359,000.00 | 883,696,000.00 | ||||||||||||